Spondyloarthritis
103
11
17
51
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Research Maturity
51 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.9%
5 terminated out of 103 trials
91.1%
+4.5% vs benchmark
19%
20 trials in Phase 3/4
18%
9 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 51 completed trials
Clinical Trials (103)
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research
Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism
Tai Chi in Spondyloarthritis
The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint Disease
Confinement and Spondyloarthritis Treatment
Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease.
Evaluation of Plasma Vitamin C Levels in a Population of Chronic Rheumatism in Immuno-Rheumatology
Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
Pregnancy and Medically Assisted Conception in Rare Diseases
Move Your Spondyl " Better Live Its Rheumatism With the Physical Activity "
Biobank for Inflammatory Chronic Diseases and Osteoporosis
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis
The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry
Dynamic and Static Balance and the Speed of Reaction in the Elderly
Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement